Re: Question on Rosuvastatin versus Astorvastatin
|
5
|
Resverlogix Corp.
|
Sep 06, 2019 02:34PM
|
Re: Zenith MD&A and Financials are up
|
4
|
Zenith Epigenetics
|
Sep 05, 2019 03:00PM
|
Re: Warrants
|
3
|
Resverlogix Corp.
|
Aug 30, 2019 11:24AM
|
Re: Insider selling - timeline
|
3
|
Resverlogix Corp.
|
Aug 28, 2019 10:58AM
|
Re: Insider selling - timeline
|
1
|
Resverlogix Corp.
|
Aug 28, 2019 10:40AM
|
Re: Insider selling - timeline
|
1
|
Resverlogix Corp.
|
Aug 28, 2019 10:14AM
|
Re: Why worry about the Third Eye loan?
|
3
|
Resverlogix Corp.
|
Aug 27, 2019 04:53PM
|
Re: Timelines
|
6
|
Resverlogix Corp.
|
Aug 27, 2019 04:08AM
|
TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 24, 2019 10:28PM
|
Re: A birthday present for DM?
|
3
|
Resverlogix Corp.
|
Aug 20, 2019 04:43PM
|
Re: New PP on Aug 13
|
4
|
Zenith Epigenetics
|
Aug 20, 2019 03:25AM
|
Re: News - NR was issued by Eastern Cap, not RVX if interested
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 09:01PM
|
Re: News
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 07:24PM
|
Re: News
|
3
|
Resverlogix Corp.
|
Aug 12, 2019 07:10PM
|
Re: Financials
|
6
|
Zenith Epigenetics
|
Aug 09, 2019 11:26AM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
5
|
Zenith Epigenetics
|
Aug 08, 2019 03:20PM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
5
|
Zenith Epigenetics
|
Aug 06, 2019 01:20PM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 10:49AM
|
Re: Resverlogix Announces Loan Reduction and Extension
|
3
|
Resverlogix Corp.
|
Aug 02, 2019 12:22PM
|
Re: Liquidity
|
5
|
Zenith Epigenetics
|
Aug 02, 2019 12:15PM
|